Back to discover
Drug

Adenosine Monophosphate

In clinical development
Emerging researchLate-stage development
Also known as 5'-AMP, 5'-Adenylic acid, 5'-O-Phosphonoadenosine, A5MP+20 more

5'-AMP, 5'-Adenylic acid, 5'-O-Phosphonoadenosine, A5MP, AMP, Adenosine, Adenosine-5'-monophosphoric acid, Adenosine-5'P, Adenosini phosphas, Adenylic acid, Ado5'P, Fosfato de adenosina, Muscle adenylic acid, My-O-Den, PAdo, 5'-Adenosine monophosphate, ADENOSINE PHOSPHATE, AMP - Adenosine monophosphate, Adenosine 5'-(dihydrogen phosphate), Adenosine 5'-monophosphate, Adenosine-5'-Monophosphate, Adenosine-5-Monophosphate, Phosphate d'adénosine, adenosine-5 monophosphate.

RxNorm309ChEMBLCHEMBL752UNII415SHH325A
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Adenosine Monophosphate
Aliases & brands
5'-AMP5'-Adenylic acid5'-O-PhosphonoadenosineA5MPAMPAdenosineAdenosine-5'-monophosphoric acidAdenosine-5'PAdenosini phosphasAdenylic acidAdo5'PFosfato de adenosinaMuscle adenylic acidMy-O-DenPAdo5'-Adenosine monophosphateADENOSINE PHOSPHATEAMP - Adenosine monophosphateAdenosine 5'-(dihydrogen phosphate)Adenosine 5'-monophosphateAdenosine-5'-MonophosphateAdenosine-5-MonophosphatePhosphate d'adénosineadenosine-5 monophosphate
RxNorm CUI
309
ChEMBL ID
CHEMBL752
UNII
415SHH325A

Clinical trials

3 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
3
registered trials across all phases
LATEST COMPLETION 2021
2
Late-stage (III+)
2
Completed
1
Discontinued
PHASE DISTRIBUTIONn = 3
Early Phase 11Phase 41Phase N / A1

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Comparison of Different Methodologies Assessing Airway Responsiveness and Investigation of Treatment Efficacy of Budesonide /Formoterol in Asthmatics

Unknown statusPH IVZhujiang Hospitaln=802016

Recent completions

Trials that read out recently, adding to the completed evidence base.

Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults

CompletedPH IColorado State Universityn=92021

A Preliminary Investigation of Individual Differences in Subjective Responses to D-amphetamine, Alcohol, and Delta-9-tetrahydrocannabinol

CompletedN/AUniversity of Chicagon=282013

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Journals, researchers & institutions
Top journals
  • The Journal of biological chemistry1
Leading researchers
  • Feng JY1
  • Gordon CJ1
  • Götte M1
  • Porter DP1
  • Tchesnokov EP1
Leading institutions
free-text, unnormalised
  • Li Ka Shing Institute of Virology at University of Alberta1
  • University of Alberta1

Related drugs

2 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Alanine

Frequently co-studied with Adenosine Monophosphate in the research literature.

1 shared paper
Remdesivir

Frequently co-studied with Adenosine Monophosphate in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials